• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Inpatient intensification of hypertension treatment in older men associated with adverse events

byJalal EbrahimandAnees Daud
August 26, 2019
in Cardiology, Chronic Disease, Public Health
Reading Time: 3 mins read
1
Share on FacebookShare on Twitter

1. In this large, retrospective cohort study of veteran’s health administration (VHA) hospitals, males admitted to the hospital for non-cardiac reasons who had an intensification of their antihypertensive regimen before discharge had an increased risk of readmission and serious adverse events.

2. There was no difference in cardiac events or changes in systolic blood pressure after one year.

Evidence Rating Level: 2 (Good)

Study Rundown: Hypertension is one of the most prevalent chronic diseases in North America, and medications for this are frequently adjusted during inpatient admissions. This was a large, retrospective, cohort study conducted at VHA hospitals. Investigators studied patients admitted to the hospital for pneumonia, urinary tract infection, or venous thromboembolism. They found that adding a new antihypertensive medication, or increasing the dose of an existing medication by at least 20%, was associated with increased risk of readmission, medication related serious adverse events, and cardiovascular events at 30 days. A sensitivity analysis suggested this was driven largely by patients with normal outpatient blood pressure measurement prior to admission. There was no impact on mortality, systolic blood pressure at one year, or cardiovascular events at one year.

Limitations of this study included the limited range of admission diagnoses as well as the almost entirely male population. If available, recent outpatient blood pressure monitoring could help identify patients at highest risk of harm from such medication changes.

Click to read the study in JAMA Internal Medicine

Relevant Reading: Intensification of older adults’ outpatient blood pressure treatment at hospital discharge: national retrospective cohort study

RELATED REPORTS

Intensive blood pressure lowering by non-physician healthcare providers significantly reduces the risk of cardiovascular disease

Ultrasound renal denervation associated with reduced blood pressure in the RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials – A pooled analysis

Endovascular ultrasound renal denervation associated with lower ambulatory systolic blood pressure in patients with hypertension – The RADIANCE II randomized clinical trial

In-Depth [retrospective cohort]: This was a retrospective cohort study of 4056 propensity matched older adults (age over 65) hospitalized between January 2011 and December 2013 at a VHA hospital. Over 97% of patients were male. Patients must have been admitted for either pneumonia, urinary tract infection, or venous thromboembolism. Intervention of interest was intensification of antihypertensive therapy, defined as new antihypertensive medication or dose increase of at least 20% of existing medication. Primary outcomes included 30 day readmission rates, medication related serious adverse events (SAE) within 30 days, and cardiovascular events within 1 year. Cardiovascular events were defined as emergency room visit or hospitalization for acute myocardial infarction, unstable angina, stroke, heart failure, or hypertension. Secondary outcomes included readmission rate, SAE rate, change in systolic blood pressure, and all-cause mortality at 1 year, as well as cardiovascular events and all-cause mortality at 30 days.

Patients with antihypertensive intensification had higher 30 day readmission rates (21.4% vs 17.7%, HR 1.23, 95% CI 1.07-1.42, NNH 27), and higher rates of medication related SAE within 30 days (4.5% vs 3.1%, HR 1.41, 95% CI 1.06-1.88, NNH 63). They also had higher rates of cardiovascular events at 30 days (3.6% vs 2.2%, HR 1.65, 95% CI 1.13-2.40). There was no difference in cardiovascular events at one year or systolic blood pressure at one year. There was no difference in any of the other secondary outcomes. Sensitivity analysis showed the significant differences above were driven entirely by the subgroup of patients with normal pre-admission blood pressure (mean systolic blood pressure 125 mmHg).

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adverse eventsantihypertensivesblood pressurehypertension
Previous Post

Electronic nicotine delivery system marketing associated with subsequent first-time use among youth

Next Post

#VisualAbstract: Association of Lifestyle and Genetic Risk With Incidence of Dementia

RelatedReports

Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

Intensive blood pressure lowering by non-physician healthcare providers significantly reduces the risk of cardiovascular disease

March 30, 2023
UTI associated with increased risk of preeclampsia
Cardiology

Ultrasound renal denervation associated with reduced blood pressure in the RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials – A pooled analysis

March 6, 2023
Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

Endovascular ultrasound renal denervation associated with lower ambulatory systolic blood pressure in patients with hypertension – The RADIANCE II randomized clinical trial

March 6, 2023
Provision of medically-tailored meals linked with lower admissions and medical spending
Cardiology

Dietary insoluble fiber intake may be associated with lower risk of hypertension

February 22, 2023
Next Post
#VisualAbstract: Association of Lifestyle and Genetic Risk With Incidence of Dementia

#VisualAbstract: Association of Lifestyle and Genetic Risk With Incidence of Dementia

Evidence-based interventions for pediatric asthma successfully adapted for community health centers

2 Minute Medicine Rewind August 26, 2019

#VisualAbstract: Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine

#VisualAbstract: Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine

Please login to join discussion

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Addition of fludrocortisone to hydrocortisone is beneficial in management of septic shock
  • Surveillance testing of staff at nursing facilities reduces resident COVID-19 mortality
  • Childhood maltreatment may cause mental health problems
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options